<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM">
      <PMID Version="1">25482632</PMID>
      <DateCompleted>
        <Year>2015</Year>
        <Month>08</Month>
        <Day>06</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2018</Year>
        <Month>11</Month>
        <Day>13</Day>
      </DateRevised>
      <Article PubModel="Print">
        <Journal>
          <ISSN IssnType="Electronic">1933-6926</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>8</Volume>
            <Issue>4</Issue>
            <PubDate>
              <Year>2014</Year>
            </PubDate>
          </JournalIssue>
          <Title>Cell adhesion &amp; migration</Title>
          <ISOAbbreviation>Cell Adh Migr</ISOAbbreviation>
        </Journal>
        <ArticleTitle>The role of proteases in regulating Eph/ephrin signaling.</ArticleTitle>
        <Pagination>
          <StartPage>294</StartPage>
          <EndPage>307</EndPage>
          <MedlinePgn>294-307</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.4161/19336918.2014.970026</ELocationID>
        <Abstract>
          <AbstractText>Proteases regulate a myriad of cell functions, both in normal and disease states. In addition to protein turnover, they regulate a range of signaling processes, including those mediated by Eph receptors and their ephrin ligands. A variety of proteases is reported to directly cleave Ephs and/or ephrins under different conditions, to promote receptor and/or ligand shedding, and regulate receptor/ligand internalisation and signaling. They also cleave other adhesion proteins in response to Eph-ephrin interactions, to indirectly facilitate Eph-mediated functions. Proteases thus contribute to Eph/ephrin mediated changes in cell-cell and cell-matrix interactions, in cell morphology and in cell migration and invasion, in a manner which appears to be tightly regulated by, and co-ordinated with, Eph signaling. This review summarizes the current literature describing the function and regulation of protease activities during Eph/ephrin-mediated cell signaling.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Atapattu</LastName>
            <ForeName>Lakmali</ForeName>
            <Initials>L</Initials>
            <AffiliationInfo>
              <Affiliation>a Department of Biochemistry and Molecular Biology ; Monash University , Victoria ; Australia.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Lackmann</LastName>
            <ForeName>Martin</ForeName>
            <Initials>M</Initials>
          </Author>
          <Author ValidYN="Y">
            <LastName>Janes</LastName>
            <ForeName>Peter W</ForeName>
            <Initials>PW</Initials>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
          <PublicationType UI="D016454">Review</PublicationType>
        </PublicationTypeList>
      </Article>
      <MedlineJournalInfo>
        <MedlineTA>Cell Adh Migr</MedlineTA>
        <NlmUniqueID>101469464</NlmUniqueID>
        <ISSNLinking>1933-6918</ISSNLinking>
      </MedlineJournalInfo>
      <ChemicalList>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D036342">Ephrins</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D008024">Ligands</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>EC 2.7.10.1</RegistryNumber>
          <NameOfSubstance UI="D036081">Receptors, Eph Family</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>EC 3.4.-</RegistryNumber>
          <NameOfSubstance UI="D010447">Peptide Hydrolases</NameOfSubstance>
        </Chemical>
      </ChemicalList>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D002448" MajorTopicYN="N">Cell Adhesion</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D002450" MajorTopicYN="N">Cell Communication</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D002465" MajorTopicYN="Y">Cell Movement</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D036342" MajorTopicYN="N">Ephrins</DescriptorName>
          <QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008024" MajorTopicYN="N">Ligands</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D010447" MajorTopicYN="N">Peptide Hydrolases</DescriptorName>
          <QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D011485" MajorTopicYN="N">Protein Binding</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D036081" MajorTopicYN="N">Receptors, Eph Family</DescriptorName>
          <QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D015398" MajorTopicYN="Y">Signal Transduction</DescriptorName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">AD, Alzheimer's disease; ADAM, a disintegrin and metalloprotease; APP, Amyloid precursor protein; Arf1, ADP rybosylation factor 1; BACE, β-site APP cleaving enzyme; CAM, cell adhesion molecules; CTF, cytoplasmic fragment; CNC, cranial neural crest; ECM, </Keyword>
        <Keyword MajorTopicYN="N">ADAM</Keyword>
        <Keyword MajorTopicYN="N">Eph receptor tyrosine kinase</Keyword>
        <Keyword MajorTopicYN="N">MMP</Keyword>
        <Keyword MajorTopicYN="N">ephrin signaling</Keyword>
        <Keyword MajorTopicYN="N">protease</Keyword>
        <Keyword MajorTopicYN="N">γ-secretase</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2014</Year>
          <Month>12</Month>
          <Day>9</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2014</Year>
          <Month>12</Month>
          <Day>9</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2015</Year>
          <Month>8</Month>
          <Day>8</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">25482632</ArticleId>
        <ArticleId IdType="pmc">PMC4594553</ArticleId>
        <ArticleId IdType="doi">10.4161/19336918.2014.970026</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>
Serim S, Haedke U, Verhelst SHL. Activity-based probes for the study of proteases: recent advances and developments. ChemMedChem
2012; 7:1146-59; PMID:22431376; http://dx.doi.org/10.1002/cmdc.201200057</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/cmdc.201200057</ArticleId>
            <ArticleId IdType="pubmed">22431376</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Drag M, Salvesen GS. Emerging principles in protease-based drug discovery. Nat Rev Drug Discov
2010; 9:690-701; PMID:20811381; http://dx.doi.org/10.1038/nrd3053</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/nrd3053</ArticleId>
            <ArticleId IdType="pmc">PMC2974563</ArticleId>
            <ArticleId IdType="pubmed">20811381</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Turk B. Targeting proteases: successes, failures and future prospects. Nat Rev Drug Dis
2006; 5:785-99; PMID:16955069; http://dx.doi.org/10.1038/nrd2092</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/nrd2092</ArticleId>
            <ArticleId IdType="pubmed">16955069</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Lopez-Otin C, Bond JS. Proteases: multifunctional enzymes in life and disease. J Biol Chem
2008; 283:30433-7; PMID:18650443; http://dx.doi.org/10.1074/jbc.R800035200</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1074/jbc.R800035200</ArticleId>
            <ArticleId IdType="pmc">PMC2576539</ArticleId>
            <ArticleId IdType="pubmed">18650443</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Overall CM, Blobel CP. In search of partners: linking extracellular proteases to substrates. Nat Rev Mol Cell Biol
2007; 8:245-57; PMID:17299501; http://dx.doi.org/10.1038/nrm2120</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/nrm2120</ArticleId>
            <ArticleId IdType="pubmed">17299501</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Turk B, Turk D, Turk V. Protease signalling: the cutting edge. EMBO J
2012; 31:1630-43; PMID:22367392; http://dx.doi.org/10.1038/emboj.2012.42</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/emboj.2012.42</ArticleId>
            <ArticleId IdType="pmc">PMC3321211</ArticleId>
            <ArticleId IdType="pubmed">22367392</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Adrain C, Freeman M. Regulation of receptor tyrosine kinase ligand processing. Cold Spring Harb Perspect Biol
2014; 6:pii: a008995; PMID:24384567; http://dx.doi.org/10.1101/cshperspect.a008995
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1101/cshperspect.a008995</ArticleId>
            <ArticleId IdType="pmc">PMC3941217</ArticleId>
            <ArticleId IdType="pubmed">24384567</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Nievergall E, Lackmann M, Janes PW. Eph-dependent cell-cell adhesion and segregation in development and cancer. Cell Mol Life Sci
2012; 69:1813-42; PMID:22204021; http://dx.doi.org/10.1007/s00018-011-0900-6</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s00018-011-0900-6</ArticleId>
            <ArticleId IdType="pubmed">22204021</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Marston DJ, Dickinson S, Nobes CD. Rac-dependent trans-endocytosis of ephrinBs regulates Eph-ephrin contact repulsion. Nat Cell Biol
2003; 5:879-88; PMID:12973357; http://dx.doi.org/10.1038/ncb1044</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/ncb1044</ArticleId>
            <ArticleId IdType="pubmed">12973357</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Klein T, Bischoff R. Active metalloproteases of the A Disintegrin and Metalloprotease (ADAM) family: biological function and structure. J Proteome Res
2011; 10:17-33; PMID:20849079; http://dx.doi.org/10.1021/pr100556z</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1021/pr100556z</ArticleId>
            <ArticleId IdType="pubmed">20849079</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Wolfsberg TG, White JM. 
207–ADAM metalloproteinases. In: Barrett AJ, Rawlings ND, Woessner JF, eds. Handbook of Proteolytic Enzymes. Second Edition
London: Academic Press, 2004:709-14</Citation>
        </Reference>
        <Reference>
          <Citation>
Weber S, Saftig P. Ectodomain shedding and ADAMs in development. Development (Cambridge, England)
2012; 139:3693-709; PMID:22991436; http://dx.doi.org/10.1242/dev.076398</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1242/dev.076398</ArticleId>
            <ArticleId IdType="pubmed">22991436</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Reiss K, Saftig P. The “a disintegrin and metalloprotease” (ADAM) family of sheddases: physiological and cellular functions. Semin Cell Dev Biol
2009; 20:126-37; PMID:19049889; http://dx.doi.org/10.1016/j.semcdb.2008.11.002</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.semcdb.2008.11.002</ArticleId>
            <ArticleId IdType="pubmed">19049889</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Tousseyn T, Jorissen E, Reiss K, Hartmann D. (Make) stick and cut loose–disintegrin metalloproteases in development and disease. Birth Defects Res C Embryo Today
2006; 78:24-46; PMID:16622847; http://dx.doi.org/10.1002/bdrc.20066</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/bdrc.20066</ArticleId>
            <ArticleId IdType="pubmed">16622847</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Kurohara K, Komatsu K, Kurisaki T, Masuda A, Irie N, Asano M, Sudo K, Nabeshima Y, Iwakura Y, Sehara-Fujisawa A. Essential roles of Meltrin beta (ADAM19) in heart development. Dev Biol
2004; 267:14-28; PMID:14975714; http://dx.doi.org/10.1016/j.ydbio.2003.10.021
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.ydbio.2003.10.021</ArticleId>
            <ArticleId IdType="pubmed">14975714</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Murphy G. The ADAMs: signalling scissors in the tumour microenvironment. Nat Rev Cancer
2008; 8:929-41; PMID:19005493; http://dx.doi.org/10.1038/nrc2459</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/nrc2459</ArticleId>
            <ArticleId IdType="pubmed">19005493</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Blobel CP. ADAMs: key components in EGFR signalling and development. Nat Rev Mol Cell Biol
2005; 6:32-43; PMID:15688065; http://dx.doi.org/10.1038/nrm1548</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/nrm1548</ArticleId>
            <ArticleId IdType="pubmed">15688065</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Loechel F, Overgaard MT, Oxvig C, Albrechtsen R, Wewer UM. Regulation of human ADAM 12 protease by the prodomain. Evidence for a functional cysteine switch. J Biol Chem
1999; 274:13427-33; PMID:10224107; http://dx.doi.org/10.1074/jbc.274.19.13427</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1074/jbc.274.19.13427</ArticleId>
            <ArticleId IdType="pubmed">10224107</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Anders A, Gilbert S, Garten W, Postina R, Fahrenholz F. Regulation of the alpha-secretase ADAM10 by its prodomain and proprotein convertases. FASEB J
2001; 15:1837-9; PMID:11481247</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">11481247</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Seals DF, Courtneidge SA. The ADAMs family of metalloproteases: multidomain proteins with multiple functions. Genes Dev
2003; 17:7-30; PMID:12514095; http://dx.doi.org/10.1101/gad.1039703</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1101/gad.1039703</ArticleId>
            <ArticleId IdType="pubmed">12514095</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Fahrenholz F, Gilbert S, Kojro E, Lammich S, Postina R. Alpha-secretase activity of the disintegrin metalloprotease ADAM 10. Influences of domain structure. Ann N Y Acad Sci
2000; 920:215-22; PMID:11193153; http://dx.doi.org/10.1111/j.1749-6632.2000.tb06925.x</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/j.1749-6632.2000.tb06925.x</ArticleId>
            <ArticleId IdType="pubmed">11193153</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Howard L, Maciewicz RA, Blobel CP. Cloning and characterization of ADAM28: evidence for autocatalytic pro-domain removal and for cell surface localization of mature ADAM28. Biochem J
2000; 348
Pt 1:21-7; PMID:10794709; http://dx.doi.org/10.1042/0264-6021:3480021</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1042/0264-6021:3480021</ArticleId>
            <ArticleId IdType="pmc">PMC1221031</ArticleId>
            <ArticleId IdType="pubmed">10794709</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Roghani M, Becherer JD, Moss ML, Atherton RE, Erdjument-Bromage H, Arribas J, Blackburn RK, Weskamp G, Tempst P, Blobel CP. Metalloprotease-disintegrin MDC9: intracellular maturation and catalytic activity. J Biol Chem
1999; 274:3531-40; PMID:9920899; http://dx.doi.org/10.1074/jbc.274.6.3531</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1074/jbc.274.6.3531</ArticleId>
            <ArticleId IdType="pubmed">9920899</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Lum L, Reid MS, Blobel CP. Intracellular maturation of the mouse metalloprotease disintegrin MDC15. J Biol Chem
1998; 273:26236-47; PMID:9748307; http://dx.doi.org/10.1074/jbc.273.40.26236</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1074/jbc.273.40.26236</ArticleId>
            <ArticleId IdType="pubmed">9748307</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Laisney JAGC, Mueller TD, Schartl M, Meierjohann S. Hyperactivation of constitutively dimerized oncogenic EGF receptors by autocrine loops. Oncogene
2013; 32:2403-11; PMID:22751127; http://dx.doi.org/10.1038/onc.2012.267</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/onc.2012.267</ArticleId>
            <ArticleId IdType="pubmed">22751127</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Moss ML, Bomar M, Liu Q, Sage H, Dempsey P, Lenhart PM, Gillispie PA, Stoeck A, Wildeboer D, Bartsch JW, et al. . 
The ADAM10 prodomain is a specific inhibitor of ADAM10 proteolytic activity and inhibits cellular shedding events. J Biol Chem
2007; 282:35712-21; PMID:17895248; http://dx.doi.org/10.1074/jbc.M703231200</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1074/jbc.M703231200</ArticleId>
            <ArticleId IdType="pubmed">17895248</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Loechel F, Gilpin BJ, Engvall E, Albrechtsen R, Wewer UM. Human ADAM 12 (meltrin alpha) is an active metalloprotease. J Biol Chem
1998; 273:16993-7; PMID:9642263; http://dx.doi.org/10.1074/jbc.273.27.16993</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1074/jbc.273.27.16993</ArticleId>
            <ArticleId IdType="pubmed">9642263</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Saftig P, Reiss K. The “A Disintegrin And Metalloproteases” ADAM10 and ADAM17: novel drug targets with therapeutic potential?
Eur J Cell Biol
2011; 90:527-35; PMID:21194787; http://dx.doi.org/10.1016/j.ejcb.2010.11.005</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.ejcb.2010.11.005</ArticleId>
            <ArticleId IdType="pubmed">21194787</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
White JM. ADAMs: modulators of cell–cell and cell–matrix interactions. Curr Opin Cell Biol
2003; 15:598-606; PMID:14519395; http://dx.doi.org/10.1016/j.ceb.2003.08.001</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.ceb.2003.08.001</ArticleId>
            <ArticleId IdType="pubmed">14519395</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Caescu CI, Jeschke GR, Turk BE. Active-site determinants of substrate recognition by the metalloproteinases TACE and ADAM10. Biochem J
2009; 424:79-88; PMID:19715556; http://dx.doi.org/10.1042/BJ20090549</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1042/BJ20090549</ArticleId>
            <ArticleId IdType="pmc">PMC2774824</ArticleId>
            <ArticleId IdType="pubmed">19715556</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Moss ML, Lambert MH. Shedding of membrane proteins by ADAM family proteases. Essays Biochem
2002; 38:141-53; PMID:12463167</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">12463167</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Smith KM, Gaultier A, Cousin H, Alfandari D, White JM, DeSimone DW. The cysteine-rich domain regulates ADAM protease function in vivo. J Cell Biol
2002; 159:893-902; PMID:12460986; http://dx.doi.org/10.1083/jcb.200206023</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1083/jcb.200206023</ArticleId>
            <ArticleId IdType="pmc">PMC2173380</ArticleId>
            <ArticleId IdType="pubmed">12460986</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Alfandari D.
ADAM13 Function in Development. In: Hooper N, Lendeckel U, eds. The ADAM Family of Proteases: Springer; 
US, 2005:147-69</Citation>
        </Reference>
        <Reference>
          <Citation>
Reddy P, Slack JL, Davis R, Cerretti DP, Kozlosky CJ, Blanton RA, Shows D, Peschon JJ, Black RA. Functional analysis of the domain structure of tumor necrosis factor-α converting enzyme. J Biol Chem
2000; 275:14608-14; PMID:10799547; http://dx.doi.org/10.1074/jbc.275.19.14608</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1074/jbc.275.19.14608</ArticleId>
            <ArticleId IdType="pubmed">10799547</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Janes PW, Saha N, Barton WA, Kolev MV, Wimmer-Kleikamp SH, Nievergall E, Blobel CP, Himanen JP, Lackmann M, Nikolov DB. Adam meets Eph: an ADAM substrate recognition module acts as a molecular switch for ephrin cleavage in trans. Cell
2005; 123:291-304; PMID:16239146; http://dx.doi.org/10.1016/j.cell.2005.08.014</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.cell.2005.08.014</ArticleId>
            <ArticleId IdType="pubmed">16239146</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Maskos K, Fernandez-Catalan C, Huber R, Bourenkov GP, Bartunik H, Ellestad GA, Reddy P, Wolfson MF, Rauch CT, Castner BJ, et al. .  Crystal structure of the catalytic domain of human tumor necrosis factor-Î±-converting enzyme. Proc Natl Acad Sci U S A
1998; 95:3408-12; PMID:9520379; http://dx.doi.org/10.1073/pnas.95.7.3408</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1073/pnas.95.7.3408</ArticleId>
            <ArticleId IdType="pmc">PMC19849</ArticleId>
            <ArticleId IdType="pubmed">9520379</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Takeda S, Igarashi T, Mori H, Araki S. Crystal structures of VAP1 reveal ADAMs’ MDC domain architecture and its unique C-shaped scaffold. EMBO J
2006; 25:2388-96; PMID:16688218; http://dx.doi.org/10.1038/sj.emboj.7601131</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/sj.emboj.7601131</ArticleId>
            <ArticleId IdType="pmc">PMC1478178</ArticleId>
            <ArticleId IdType="pubmed">16688218</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Kullander K, Klein R. Mechanisms and functions of eph and ephrin signalling. Nat Rev Mol Cell Biol
2002; 3:475-86; PMID:12094214; http://dx.doi.org/10.1038/nrm856</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/nrm856</ArticleId>
            <ArticleId IdType="pubmed">12094214</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Hattori M, Osterfield M, Flanagan JG. Regulated cleavage of a contact-mediated axon repellent. Science
2000; 289:1360-5; PMID:10958785; http://dx.doi.org/10.1126/science.289.5483.1360</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1126/science.289.5483.1360</ArticleId>
            <ArticleId IdType="pubmed">10958785</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Sahin U, Weskamp G, Kelly K, Zhou H-M, Higashiyama S, Peschon J, Hartmann D, Saftig P, Blobel CP. Distinct roles for ADAM10 and ADAM17 in ectodomain shedding of six EGFR ligands. J Cell Biol
2004; 164:769-79; PMID:14993236; http://dx.doi.org/10.1083/jcb.200307137</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1083/jcb.200307137</ArticleId>
            <ArticleId IdType="pmc">PMC2172154</ArticleId>
            <ArticleId IdType="pubmed">14993236</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Luo X, Prior M, He W, Hu X, Tang X, Shen W, Yadav S, Kiryu-Seo S, Miller R, Trapp s, et al. . 
Cleavage of neuregulin-1 by BACE1 or ADAM10 protein produces differential effects on myelination. J Biol Chem
2011; 286:23967-74; PMID:21576249; http://dx.doi.org/10.1074/jbc.M111.251538</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1074/jbc.M111.251538</ArticleId>
            <ArticleId IdType="pmc">PMC3129178</ArticleId>
            <ArticleId IdType="pubmed">21576249</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Pruessmeyer J, Ludwig A. The good, the bad and the ugly substrates for ADAM10 and ADAM17 in brain pathology, inflammation and cancer. Semin Cell Dev Biol
2009; 20:164-74; PMID:18951988; http://dx.doi.org/10.1016/j.semcdb.2008.09.005</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.semcdb.2008.09.005</ArticleId>
            <ArticleId IdType="pubmed">18951988</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Abel S, Hundhausen C, Mentlein R, Schulte A, Berkhout TA, Broadway N, Hartmann D, Sedlacek R, Dietrich S, Muetze B, et al. . 
The transmembrane CXC-chemokine ligand 16 is induced by IFN-gamma and TNF-alpha and shed by the activity of the disintegrin-like metalloproteinase ADAM10. J Immunol
2004; 172:6362-72; PMID:15128827; http://dx.doi.org/10.4049/jimmunol.172.10.6362</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.4049/jimmunol.172.10.6362</ArticleId>
            <ArticleId IdType="pubmed">15128827</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Hundhausen C, Misztela D, Berkhout TA, Broadway N, Saftig P, Reiss K, Hartmann D, Fahrenholz F, Postina R, Matthews V, et al. . 
The disintegrin-like metalloproteinase ADAM10 is involved in constitutive cleavage of CX3CL1 (fractalkine) and regulates CX3CL1-mediated cell-cell adhesion. Blood
2003; 102:1186-95; PMID:12714508; http://dx.doi.org/10.1182/blood-2002-12-3775</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1182/blood-2002-12-3775</ArticleId>
            <ArticleId IdType="pubmed">12714508</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Maretzky T, Reiss K, Ludwig A, Buchholz J, Scholz F, Proksch E, de Strooper B, Hartmann D, Saftig P. ADAM10 mediates E-cadherin shedding and regulates epithelial cell-cell adhesion, migration, and β-catenin translocation. Proc Natl Acad Sci U S A
2005; 102:9182-7; PMID:15958533; http://dx.doi.org/10.1073/pnas.0500918102</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1073/pnas.0500918102</ArticleId>
            <ArticleId IdType="pmc">PMC1166595</ArticleId>
            <ArticleId IdType="pubmed">15958533</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Reiss K, Maretzky T, Ludwig A, Tousseyn T, de Strooper B, Hartmann D, Saftig P. 
ADAM10 cleavage of N-cadherin and regulation of cell–cell adhesion and β-catenin nuclear signalling. EMBO J
2005; 24:742–52. </Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC549617</ArticleId>
            <ArticleId IdType="pubmed">15692570</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Gutwein P, Mechtersheimer S, Riedle S, Stoeck A, Gast D, Joumaa S, Zentgraf H, Fogel M, Altevogt DP. ADAM10-mediated cleavage of L1 adhesion molecule at the cell surface and in released membrane vesicles. FASEB J
2003; 17:292-4; PMID:12475894</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">12475894</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Kuhn PH, Wang H, Dislich B, Colombo A, Zeitschel U, Ellwart JW, Kremmer E, Rossner S, Lichtenthaler SF. ADAM10 is the physiologically relevant, constitutive alpha-secretase of the amyloid precursor protein in primary neurons. EMBO J
2010; 29:3020-32; PMID:20676056; http://dx.doi.org/10.1038/emboj.2010.167</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/emboj.2010.167</ArticleId>
            <ArticleId IdType="pmc">PMC2944055</ArticleId>
            <ArticleId IdType="pubmed">20676056</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Vincent B, Paitel E, Saftig P, Frobert Y, Hartmann D, De Strooper B, Grassi J, Lopez-Perez E, Checler F. The disintegrins ADAM10 and TACE contribute to the constitutive and phorbol ester-regulated normal cleavage of the cellular prion protein. J Biol Chem
2001; 276:37743-6; PMID:11477090; http://dx.doi.org/10.1074/jbc.M003965200</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1074/jbc.M003965200</ArticleId>
            <ArticleId IdType="pubmed">11477090</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Ludwig A, Hundhausen C, Lambert MH, Broadway N, Andrews RC, Bickett DM, Leesnitzer MA, Becherer JD. Metalloproteinase inhibitors for the disintegrin-like metalloproteinases ADAM10 and ADAM17 that differentially block constitutive and phorbol ester-inducible shedding of cell surface molecules. Comb Chem High Throughput Screen
2005; 8:161-71; PMID:15777180; http://dx.doi.org/10.2174/1386207053258488</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.2174/1386207053258488</ArticleId>
            <ArticleId IdType="pubmed">15777180</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Bray SJ. Notch signalling: a simple pathway becomes complex. Nat Rev Mol Cell Biol
2006; 7:678-89; PMID:16921404; http://dx.doi.org/10.1038/nrm2009</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/nrm2009</ArticleId>
            <ArticleId IdType="pubmed">16921404</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
D’Souza B, Miyamoto A, Weinmaster G. 
The many facets of Notch ligands. Oncogene
2008; 27:5148-67; http://dx.doi.org/10.1038/onc.2008.229</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/onc.2008.229</ArticleId>
            <ArticleId IdType="pmc">PMC2791526</ArticleId>
            <ArticleId IdType="pubmed">18758484</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Zolkiewska A. ADAM proteases: ligand processing and modulation of the Notch pathway. Cell Mol Life Sci
2008; 65:2056-68; PMID:18344021; http://dx.doi.org/10.1007/s00018-008-7586-4</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s00018-008-7586-4</ArticleId>
            <ArticleId IdType="pmc">PMC2674646</ArticleId>
            <ArticleId IdType="pubmed">18344021</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Hartmann D, de Strooper B, Serneels L, Craessaerts K, Herreman A, Annaert W, Umans L, Lübke T, Lena Illert A, von Figura K, et al. . 
The disintegrinmetalloprotease ADAM 10 is essential for Notch signalling but not for alpha-secretase activity in fibroblasts. Hum Mol Genet
2002; 11:2615-24; PMID:12354787; http://dx.doi.org/10.1093/hmg/11.21.2615</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/hmg/11.21.2615</ArticleId>
            <ArticleId IdType="pubmed">12354787</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Mancia F, Shapiro L. ADAM and Eph: how Ephrin-signaling cells become detached. Cell
2005; 123:185-7; PMID:16239135; http://dx.doi.org/10.1016/j.cell.2005.10.004</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.cell.2005.10.004</ArticleId>
            <ArticleId IdType="pubmed">16239135</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Salaita K, Nair PM, Petit RS, Neve RM, Das D, Gray JW, Groves JT. Restriction of receptor movement alters cellular response: physical force sensing by EphA2. Science
2010; 327:1380-5; PMID:20223987; http://dx.doi.org/10.1126/science.1181729</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1126/science.1181729</ArticleId>
            <ArticleId IdType="pmc">PMC2895569</ArticleId>
            <ArticleId IdType="pubmed">20223987</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Atapattu L, Saha N, Llerena C, Vail ME, Scott AM, Nikolov DB, Lackmann M, Janes PW. Antibodies binding the ADAM10 substrate recognition domain inhibit Eph function. J Cell Sci
2012; 125:6084-93; PMID:23108669; http://dx.doi.org/10.1242/jcs.112631</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1242/jcs.112631</ArticleId>
            <ArticleId IdType="pmc">PMC3585520</ArticleId>
            <ArticleId IdType="pubmed">23108669</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Janes PW, Wimmer-Kleikamp SH, Frangakis AS, Treble K, Griesshaber B, Sabet O, Grabenbauer M, Ting AY, Saftig P, Bastiaens PI, et al. . 
Cytoplasmic relaxation of active Eph controls ephrin shedding by ADAM10. PLoS Biol
2009; 7:e1000215; PMID:19823572; http://dx.doi.org/10.1371/journal.pbio.1000215</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1371/journal.pbio.1000215</ArticleId>
            <ArticleId IdType="pmc">PMC2753297</ArticleId>
            <ArticleId IdType="pubmed">19823572</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Wybenga-Groot LE, Baskin B, Ong SH, Tong J, Pawson T, Sicheri F. Structural basis for autoinhibition of the Ephb2 receptor tyrosine kinase by the unphosphorylated juxtamembrane region. Cell
2001; 106:745-57; PMID:11572780; http://dx.doi.org/10.1016/S0092-8674(01)00496-2</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/S0092-8674(01)00496-2</ArticleId>
            <ArticleId IdType="pubmed">11572780</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Wang Y, Herrera AH, Li Y, Belani KK, Walcheck B. Regulation of mature ADAM17 by redox agents for L-selectin shedding. J Immunol
2009; 182:2449-57; PMID:19201900; http://dx.doi.org/10.4049/jimmunol.0802770</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.4049/jimmunol.0802770</ArticleId>
            <ArticleId IdType="pmc">PMC2653275</ArticleId>
            <ArticleId IdType="pubmed">19201900</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Willems SH, Tape CJ, Stanley PL, Taylor NA, Mills IG, Neal DE, McCafferty J, Murphy G, et al. . 
Thiol isomerases negatively regulate the cellular shedding activity of ADAM17. Biochem J
2010; 428:439-50; PMID:20345372; http://dx.doi.org/10.1042/BJ20100179</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1042/BJ20100179</ArticleId>
            <ArticleId IdType="pubmed">20345372</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Dusterhoft S, Jung S, Hung CW, Tholey A, Sonnichsen FD, Grotzinger J, Lorenzen I. Membrane-proximal domain of a disintegrin and metalloprotease-17 represents the putative molecular switch of its shedding activity operated by protein-disulfide isomerase. J Am Chem Soc
2013; 135:5776-81; PMID:23521534; http://dx.doi.org/10.1021/ja400340u</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1021/ja400340u</ArticleId>
            <ArticleId IdType="pubmed">23521534</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Chiarugi P, Cirri P. Redox regulation of protein tyrosine phosphatases during receptor tyrosine kinase signal transduction. Trends Biochem Sci
2003; 28:509-14; PMID:13678963; http://dx.doi.org/10.1016/S0968-0004(03)00174-9</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/S0968-0004(03)00174-9</ArticleId>
            <ArticleId IdType="pubmed">13678963</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Chiarugi P, Buricchi F. Protein tyrosine phosphorylation and reversible oxidation: two cross-talking posttranslation modifications. Antioxid Redox Signal
2007; 9:1-24; PMID:17115885; http://dx.doi.org/10.1089/ars.2007.9.1</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1089/ars.2007.9.1</ArticleId>
            <ArticleId IdType="pubmed">17115885</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
van Kempen LCL, de Visser KE, Coussens LM. Inflammation, proteases and cancer. Eur J Cancer
2006; 42:728-34; PMID:16524717; http://dx.doi.org/10.1016/j.ejca.2006.01.004</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.ejca.2006.01.004</ArticleId>
            <ArticleId IdType="pubmed">16524717</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Hartmann M, Herrlich A, Herrlich P. Who decides when to cleave an ectodomain?
Trends Biochem Sci
2013; 38:111-20; PMID:23298902; http://dx.doi.org/10.1016/j.tibs.2012.12.002</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.tibs.2012.12.002</ArticleId>
            <ArticleId IdType="pubmed">23298902</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Ji YJ, Hwang YS, Mood K, Cho HJ, Lee HS, Winterbottom E, Cousin H, Daar IO. EphrinB2 affects apical constriction in Xenopus embryos and is regulated by ADAM10 and flotillin-1. Nat Commun
2014; 5:3516; PMID:24662724</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4120273</ArticleId>
            <ArticleId IdType="pubmed">24662724</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Gauthier LR, Robbins SM. Ephrin signaling: One raft to rule them all? One raft to sort them? One raft to spread their call and in signaling bind them?
Life Sci
2003; 74:207-16; PMID:14607248; http://dx.doi.org/10.1016/j.lfs.2003.09.029</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.lfs.2003.09.029</ArticleId>
            <ArticleId IdType="pubmed">14607248</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Marquardt T, Shirasaki R, Ghosh S, Andrews SE, Carter N, Hunter T, Pfaff SL. Coexpressed EphA receptors and Ephrin-A ligands mediate opposing actions on growth cone navigation from distinct membrane domains. Cell
2005; 121:127-39; PMID:15820684; http://dx.doi.org/10.1016/j.cell.2005.01.020</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.cell.2005.01.020</ArticleId>
            <ArticleId IdType="pubmed">15820684</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Asakura M, Kitakaze M, Takashima S, Liao Y, Ishikura F, Yoshinaka T, Ohmoto H, Node K, Yoshino K, Ishiguro H, et al. . 
Cardiac hypertrophy is inhibited by antagonism of ADAM12 processing of HB-EGF: metalloproteinase inhibitors as a new therapy. Nat Med
2002; 8:35-40; PMID:11786904; http://dx.doi.org/10.1038/nm0102-35</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/nm0102-35</ArticleId>
            <ArticleId IdType="pubmed">11786904</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Roy R, Wewer UM, Zurakowski D, Pories SE, Moses MA. ADAM 12 cleaves extracellular matrix proteins and correlates with cancer status and stage. J Biol Chem
2004; 279:51323-30; PMID:15381692; http://dx.doi.org/10.1074/jbc.M409565200</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1074/jbc.M409565200</ArticleId>
            <ArticleId IdType="pubmed">15381692</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Kodama T, Ikeda E, Okada A, Ohtsuka T, Shimoda M, Shiomi T, Yoshida K, Nakada M, Ohuchi E, Okada Y. ADAM12 is selectively overexpressed in human glioblastomas and is associated with glioblastoma cell proliferation and shedding of heparin-binding epidermal growth factor. Am J Pathol
2004; 165:1743-53; PMID:15509542; http://dx.doi.org/10.1016/S0002-9440(10)63429-3</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/S0002-9440(10)63429-3</ArticleId>
            <ArticleId IdType="pmc">PMC1618672</ArticleId>
            <ArticleId IdType="pubmed">15509542</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Ieguchi K, Tomita T, Omori T, Komatsu A, Deguchi A, Masuda J, Duffy SL, Coulthard MG, Boyd A, Maru Y. ADAM12-cleaved ephrin-A1 contributes to lung metastasis. Oncogene
2014; 33:2179-90; PMID:23686306; http://dx.doi.org/10.1038/onc.2013.180</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/onc.2013.180</ArticleId>
            <ArticleId IdType="pubmed">23686306</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Frohlich C, Nehammer C, Albrechtsen R, Kronqvist P, Kveiborg M, Sehara-Fujisawa A, Mercurio AM, Wewer UM. ADAM12 produced by tumor cells rather than stromal cells accelerates breast tumor progression. Mol Cancer Res
2011; 9:1449-61; PMID:21875931; http://dx.doi.org/10.1158/1541-7786.MCR-11-0100</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1158/1541-7786.MCR-11-0100</ArticleId>
            <ArticleId IdType="pmc">PMC3219818</ArticleId>
            <ArticleId IdType="pubmed">21875931</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Wei S, Xu G, Bridges LC, Williams P, White JM, DeSimone DW. ADAM13 induces cranial neural crest by cleaving class B Ephrins and regulating Wnt signaling. Dev Cell
2010; 19:345-52; PMID:20708595; http://dx.doi.org/10.1016/j.devcel.2010.07.012</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.devcel.2010.07.012</ArticleId>
            <ArticleId IdType="pmc">PMC2951023</ArticleId>
            <ArticleId IdType="pubmed">20708595</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Gaultier A, Cousin H, Darribere T, Alfandari D. ADAM13 disintegrin and cysteine-rich domains bind to the second heparin-binding domain of fibronectin. J Biol Chem
2002; 277:23336-44; PMID:11967265; http://dx.doi.org/10.1074/jbc.M201792200</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1074/jbc.M201792200</ArticleId>
            <ArticleId IdType="pubmed">11967265</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Alfandari D, Cousin H, Gaultier A, Smith K, White JM, Darribere T, DeSimone DW. Xenopus ADAM 13 is a metalloprotease required for cranial neural crest-cell migration. Curr Biol
2001; 11:918-30; PMID:11448768; http://dx.doi.org/10.1016/S0960-9822(01)00263-9</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/S0960-9822(01)00263-9</ArticleId>
            <ArticleId IdType="pubmed">11448768</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
McCusker C, Cousin H, Neuner R, Alfandari D. Extracellular cleavage of cadherin-11 by ADAM metalloproteases is essential for Xenopus cranial neural crest cell migration. Mol Biol Cell
2009; 20:78-89; PMID:18946084; http://dx.doi.org/10.1091/mbc.E08-05-0535</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1091/mbc.E08-05-0535</ArticleId>
            <ArticleId IdType="pmc">PMC2613130</ArticleId>
            <ArticleId IdType="pubmed">18946084</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Cousin H, Abbruzzese G, Kerdavid E, Gaultier A, Alfandari D. Translocation of the cytoplasmic domain of ADAM13 to the nucleus is essential for Calpain8-a expression and cranial neural crest cell migration. Dev Cell
2011; 20:256-63; PMID:21316592; http://dx.doi.org/10.1016/j.devcel.2010.12.009</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.devcel.2010.12.009</ArticleId>
            <ArticleId IdType="pmc">PMC3074609</ArticleId>
            <ArticleId IdType="pubmed">21316592</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Krull CE, Lansford R, Gale NW, Collazo A, Marcelle C, Yancopoulos GD, Fraser SE, Bronner-Fraser M. Interactions of Eph-related receptors and ligands confer rostrocaudal pattern to trunk neural crest migration. Cu Biol
1997; 7:571-80; PMID:9259560; http://dx.doi.org/10.1016/S0960-9822(06)00256-9</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/S0960-9822(06)00256-9</ArticleId>
            <ArticleId IdType="pubmed">9259560</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Qi B, Newcomer RG, Sang Q-XA. ADAM19Adamalysin 19 structure, function, and role as a putative target in tumors and inflammatory diseases. Curr Pharm Des
2009; 15:2336-48; PMID:19601835; http://dx.doi.org/10.2174/138161209788682352</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.2174/138161209788682352</ArticleId>
            <ArticleId IdType="pubmed">19601835</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Yumoto N, Wakatsuki S, Kurisaki T, Hara Y, Osumi N, Frisen J, Sehara-Fujisawa A. Meltrin betaADAM19 interacting with EphA4 in developing neural cells participates in formation of the neuromuscular junction. PloS One
2008; 3:e3322; PMID:18830404; http://dx.doi.org/10.1371/journal.pone.0003322</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1371/journal.pone.0003322</ArticleId>
            <ArticleId IdType="pmc">PMC2552171</ArticleId>
            <ArticleId IdType="pubmed">18830404</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Solanas G, Cortina C, Sevillano M, Batlle E. Cleavage of E-cadherin by ADAM10 mediates epithelial cell sorting downstream of EphB signalling. Nat Cell Biol
2011; 13:1100-7; PMID:21804545; http://dx.doi.org/10.1038/ncb2298</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/ncb2298</ArticleId>
            <ArticleId IdType="pubmed">21804545</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Brennaman LH, Zhang X, Guan H, Triplett JW, Brown A, Demyanenko GP, Manis PB, Landmesser L, Maness PF. Polysialylated NCAM and EphrinAEphA regulate synaptic development of GABAergic interneurons in prefrontal cortex. Cereb Cortex
2013; 23:162-77; PMID:22275477; http://dx.doi.org/10.1093/cercor/bhr392</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/cercor/bhr392</ArticleId>
            <ArticleId IdType="pmc">PMC3513957</ArticleId>
            <ArticleId IdType="pubmed">22275477</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Batlle E, Henderson JT, Beghtel H, van den Born MM, Sancho E, Huls G, Meeldijk J, Robertson J, van de Wetering M, Pawson T, et al. . 
Beta-catenin and TCF mediate cell positioning in the intestinal epithelium by controlling the expression of EphBephrinB. Cell
2002; 111:251-63; PMID:12408869; http://dx.doi.org/10.1016/S0092-8674(02)01015-2</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/S0092-8674(02)01015-2</ArticleId>
            <ArticleId IdType="pubmed">12408869</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Cortina C, Palomo-Ponce S, Iglesias M, Fernandez-Masip JL, Vivancos A, Whissell G, Humà M, Peiró N, Gallego L, Jonkheer S, et al. . 
EphB-ephrin-B interactions suppress colorectal cancer progression by compartmentalizing tumor cells. Nat Genet
2007; 39:1376-83; PMID:17906625; http://dx.doi.org/10.1038/ng.2007.11</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/ng.2007.11</ArticleId>
            <ArticleId IdType="pubmed">17906625</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Chen Y, Fu AKY, Ip NY. Eph receptors at synapses: implications in neurodegenerative diseases. Cell Signal
2012; 24:606-11; PMID:22120527; http://dx.doi.org/10.1016/j.cellsig.2011.11.016</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.cellsig.2011.11.016</ArticleId>
            <ArticleId IdType="pubmed">22120527</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Brennaman LH, Moss ML, Maness PF. EphrinAEphA-induced ectodomain shedding of neural cell adhesion molecule regulates growth cone repulsion through ADAM10 metalloprotease. J Neurochem
2014; 128:267-79; PMID:24117969; http://dx.doi.org/10.1111/jnc.12468</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/jnc.12468</ArticleId>
            <ArticleId IdType="pubmed">24117969</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Page-McCaw A, Ewald AJ, Werb Z. Matrix metalloproteinases and the regulation of tissue remodelling. Nat Rev Mol Cell Biol
2007; 8:221-33; PMID:17318226; http://dx.doi.org/10.1038/nrm2125</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/nrm2125</ArticleId>
            <ArticleId IdType="pmc">PMC2760082</ArticleId>
            <ArticleId IdType="pubmed">17318226</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Parks WC, Wilson CL, Lopez-Boado YS. Matrix metalloproteinases as modulators of inflammation and innate immunity. Nat Rev Immunol
2004; 4:617-29; PMID:15286728; http://dx.doi.org/10.1038/nri1418</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/nri1418</ArticleId>
            <ArticleId IdType="pubmed">15286728</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Streuli C. Extracellular matrix remodelling and cellular differentiation. Curr Opin Cell Biol
1999; 11:634-40; PMID:10508658; http://dx.doi.org/10.1016/S0955-0674(99)00026-5</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/S0955-0674(99)00026-5</ArticleId>
            <ArticleId IdType="pubmed">10508658</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Peschon JJ, Slack JL, Reddy P, Stocking KL, Sunnarborg SW, Lee DC, Russell WE, Castner BJ, Johnson RS, Fitzner JN, et al. . 
An essential role for ectodomain shedding in mammalian development. Science
1998; 282:1281-4; PMID:9812885; http://dx.doi.org/10.1126/science.282.5392.1281</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1126/science.282.5392.1281</ArticleId>
            <ArticleId IdType="pubmed">9812885</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Palmisano R, Itoh Y. 
Analysis of MMP-Dependent Cell Migration and Invasion. Meth Molec Bio
2010; 622:379-92. </Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">20135295</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Kessenbrock K, Plaks V, Werb Z. Matrix metalloproteinases: regulators of the tumor microenvironment. Cell
2010; 141:52-67; PMID:20371345; http://dx.doi.org/10.1016/j.cell.2010.03.015</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.cell.2010.03.015</ArticleId>
            <ArticleId IdType="pmc">PMC2862057</ArticleId>
            <ArticleId IdType="pubmed">20371345</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Beauchamp A, Lively MO, Mintz A, Gibo D, Wykosky J, Debinski W. EphrinA1 is released in three forms from cancer cells by matrix metalloproteases. Mol Cell Biol
2012; 32:3253-64; PMID:22688511; http://dx.doi.org/10.1128/MCB.06791-11</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/MCB.06791-11</ArticleId>
            <ArticleId IdType="pmc">PMC3434542</ArticleId>
            <ArticleId IdType="pubmed">22688511</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Parri M, Taddei ML, Bianchini F, Calorini L, Chiarugi P. EphA2 reexpression prompts invasion of melanoma cells shifting from mesenchymal to amoeboid-like motility style. Cancer Res
2009; 69:2072-81; PMID:19244130; http://dx.doi.org/10.1158/0008-5472.CAN-08-1845</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1158/0008-5472.CAN-08-1845</ArticleId>
            <ArticleId IdType="pubmed">19244130</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Kim ES, Kim MS, Moon A. TGF-beta-induced upregulation of MMP-2 and MMP-9 depends on p38 MAPK, but not ERK signaling in MCF10A human breast epithelial cells. Int J Oncol
2004; 25:1375-82; PMID:15492828</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15492828</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Georgakopoulos A, Litterst C, Ghersi E, Baki L, Xu C, Serban G, Robakis NK. MetalloproteinasePresenilin1 processing of ephrinB regulates EphB-induced Src phosphorylation and signaling. EMBO J
2006; 25:1242-52; PMID:16511561; http://dx.doi.org/10.1038/sj.emboj.7601031</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/sj.emboj.7601031</ArticleId>
            <ArticleId IdType="pmc">PMC1422162</ArticleId>
            <ArticleId IdType="pubmed">16511561</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Tanaka M, Sasaki K, Kamata R, Sakai R. The C-terminus of ephrin-B1 regulates metalloproteinase secretion and invasion of cancer cells. J Cell Sci
2007; 120:2179-89; PMID:17567680; http://dx.doi.org/10.1242/jcs.008607</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1242/jcs.008607</ArticleId>
            <ArticleId IdType="pubmed">17567680</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Tanaka M, Kamata R, Yanagihara K, Sakai R. Suppression of gastric cancer dissemination by ephrin-B1-derived peptide. Cancer Sci
2010; 101:87-93; PMID:19804421; http://dx.doi.org/10.1111/j.1349-7006.2009.01352.x</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/j.1349-7006.2009.01352.x</ArticleId>
            <ArticleId IdType="pubmed">19804421</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Lee HS, Bong YS, Moore KB, Soria K, Moody SA, Daar IO. Dishevelled mediates ephrinB1 signalling in the eye field through the planar cell polarity pathway. Nat Cell Biol
2006; 8:55-63; PMID:16362052; http://dx.doi.org/10.1038/ncb1344</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/ncb1344</ArticleId>
            <ArticleId IdType="pubmed">16362052</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Ogawa K, Wada H, Okada N, Harada I, Nakajima T, Pasquale EB, Tsuyama S. EphB2 and ephrin-B1 expressed in the adult kidney regulate the cytoarchitecture of medullary tubule cells through Rho family GTPases. J Cell Sci
2006; 119:559-70; PMID:16443753; http://dx.doi.org/10.1242/jcs.02777</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1242/jcs.02777</ArticleId>
            <ArticleId IdType="pubmed">16443753</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Lin KT, Sloniowski S, Ethell DW, Ethell IM. Ephrin-B2-induced cleavage of EphB2 receptor is mediated by matrix metalloproteinases to trigger cell repulsion. J Biol Chem
2008; 283:28969-79; PMID:18713744; http://dx.doi.org/10.1074/jbc.M804401200</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1074/jbc.M804401200</ArticleId>
            <ArticleId IdType="pmc">PMC2570862</ArticleId>
            <ArticleId IdType="pubmed">18713744</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Moeller ML, Shi Y, Reichardt LF, Ethell IM. EphB receptors regulate dendritic spine morphogenesis through the recruitmentphosphorylation of focal adhesion kinase and RhoA activation. J Biol Chem
2006; 281:1587-98; PMID:16298995; http://dx.doi.org/10.1074/jbc.M511756200</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1074/jbc.M511756200</ArticleId>
            <ArticleId IdType="pubmed">16298995</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Chukkapalli S, Amessou M, Dilly AK, Dekhil H, Zhao J, Liu Q, Bejna A, Thomas RD, Bandyopadhyay S, Bismar TA, et al. . 
Role of the EphB2 receptor in autophagy, apoptosis and invasion in human breast cancer cells. Exp Cell Res
2014; 320:233-46; PMID:24211352; http://dx.doi.org/10.1016/j.yexcr.2013.10.022</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.yexcr.2013.10.022</ArticleId>
            <ArticleId IdType="pubmed">24211352</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Litterst C, Georgakopoulos A, Shioi J, Ghersi E, Wisniewski T, Wang R, Ludwig A, Robakis NK. Ligand binding and calcium influx induce distinct ectodomaingamma-secretase-processing pathways of EphB2 receptor. JBiol Chem
2007; 282:16155-63; PMID:17428795; http://dx.doi.org/10.1074/jbc.M611449200</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1074/jbc.M611449200</ArticleId>
            <ArticleId IdType="pmc">PMC4005067</ArticleId>
            <ArticleId IdType="pubmed">17428795</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Sugiyama N, Gucciardo E, Tatti O, Varjosalo M, Hyytiainen M, Gstaiger M, Gstaiger M, Lehti K. EphA2 cleavage by MT1-MMP triggers single cancer cell invasion via homotypic cell repulsion. J Cell Biol
2013; 201:467-84; PMID:23629968; http://dx.doi.org/10.1083/jcb.201205176</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1083/jcb.201205176</ArticleId>
            <ArticleId IdType="pmc">PMC3639392</ArticleId>
            <ArticleId IdType="pubmed">23629968</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Suenaga N, Mori H, Itoh Y, Seiki M. CD44 binding through the hemopexin-like domain is critical for its shedding by membrane-type 1 matrix metalloproteinase. Oncogene
2005; 24:859-68; PMID:15558018; http://dx.doi.org/10.1038/sj.onc.1208258</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/sj.onc.1208258</ArticleId>
            <ArticleId IdType="pubmed">15558018</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Yuan W, Chen Z, Chen Z, Wu S, Guo J, Ge J, Yang P, Huang J. Silencing of EphA2 inhibits invasion of human gastric cancer SGC-7901 cells in vitro and in vivo. Neoplasma
2012; 59:105-13; PMID:22103904; http://dx.doi.org/10.4149/neo_2012_014</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.4149/neo_2012_014</ArticleId>
            <ArticleId IdType="pubmed">22103904</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Duxbury MS, Ito H, Zinner MJ, Ashley SW, Whang EE. Ligation of EphA2 by Ephrin A1-Fc inhibits pancreatic adenocarcinoma cellular invasiveness. Biochem Biophys Res Commun
2004; 320:1096-102; PMID:15249202; http://dx.doi.org/10.1016/j.bbrc.2004.06.054</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.bbrc.2004.06.054</ArticleId>
            <ArticleId IdType="pubmed">15249202</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Noren NK, Foos G, Hauser CA, Pasquale EB. The EphB4 receptor suppresses breast cancer cell tumorigenicity through an Abl-Crk pathway. Nat Cell Biol
2006; 8:815-25; PMID:16862147; http://dx.doi.org/10.1038/ncb1438</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/ncb1438</ArticleId>
            <ArticleId IdType="pubmed">16862147</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Steinle JJ, Meininger CJ, Forough R, Wu G, Wu MH, Granger HJ. Eph B4 receptor signaling mediates endothelial cell migration and proliferation via the phosphatidylinositol 3-kinase pathway. J Biol Chem
2002; 277:43830-5; PMID:12235151; http://dx.doi.org/10.1074/jbc.M207221200</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1074/jbc.M207221200</ArticleId>
            <ArticleId IdType="pubmed">12235151</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Brown MS, Ye J, Rawson RB, Goldstein JL. Regulated intramembrane proteolysis: a control mechanism conserved from bacteria to humans. Cell
2000; 100:391-8; PMID:10693756; http://dx.doi.org/10.1016/S0092-8674(00)80675-3</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/S0092-8674(00)80675-3</ArticleId>
            <ArticleId IdType="pubmed">10693756</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Lichtenthaler SF, Haass C, Steiner H. Regulated intramembrane proteolysis - lessons from amyloid precursor protein processing. J Neurochem
2011; 117:779-96; PMID:21413990; http://dx.doi.org/10.1111/j.1471-4159.2011.07248.x</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/j.1471-4159.2011.07248.x</ArticleId>
            <ArticleId IdType="pubmed">21413990</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Murphy G, Murthy A, Khokha R. Clipping, shedding and RIPping keep immunity on cue. Trends Immunol
2008; 29:75-82; PMID:18182322; http://dx.doi.org/10.1016/j.it.2007.10.009</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.it.2007.10.009</ArticleId>
            <ArticleId IdType="pubmed">18182322</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Prox J, Rittger A, Saftig P. Physiological functions of the amyloid precursor protein secretases ADAM10, BACE1, and Presenilin. Exp Brain Res
2012; 217:331-41; PMID:22120156; http://dx.doi.org/10.1007/s00221-011-2952-0</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s00221-011-2952-0</ArticleId>
            <ArticleId IdType="pubmed">22120156</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Strooper BD, Annaert W. 
Presenilins and the intramembrane proteolysis of proteins: facts and fiction. Nat Cell Bio
2001; 3:E221-5.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">11584280</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Morohashi Y, Tomita T. Protein trafficking and maturation regulate intramembrane proteolysis. Biochim Biophys Acta
2013; 1828:2855-61; PMID:23770323; http://dx.doi.org/10.1016/j.bbamem.2013.06.001</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.bbamem.2013.06.001</ArticleId>
            <ArticleId IdType="pubmed">23770323</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Rawson RB. Regulated intramembrane proteolysis: from the endoplasmic reticulum to the nucleus. Essays Biochem
2002; 38:155-68; PMID:12463168</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">12463168</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Nakayama K, Nagase H, Koh C-S, Ohkawara T. 
γ-secretase-regulated signaling: notch, APP, and Alzheimer's disease. Curr Psychopharmacol
2012; 1:155-66; http://dx.doi.org/10.2174/2211556011201020155</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.2174/2211556011201020155</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Ni C-Y, Murphy MP, Golde TE, Carpenter G. γ-Secretase cleavage and nuclear localization of ErbB-4 receptor tyrosine kinase. Science
2001; 294:2179-81; PMID:11679632; http://dx.doi.org/10.1126/science.1065412</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1126/science.1065412</ArticleId>
            <ArticleId IdType="pubmed">11679632</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Wolfe MS. Structure, mechanism and inhibition of gamma-secretase and presenilin-like proteases. Biol Chem
2010; 391:839-47; PMID:20482315; http://dx.doi.org/10.1515/bc.2010.086</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1515/bc.2010.086</ArticleId>
            <ArticleId IdType="pmc">PMC2997569</ArticleId>
            <ArticleId IdType="pubmed">20482315</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Bergmans BA, De Strooper B. γ-secretases: from cell biology to therapeutic strategies. Lancet Neurol
2010; 9:215-26; PMID:20129170; http://dx.doi.org/10.1016/S1474-4422(09)70332-1</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/S1474-4422(09)70332-1</ArticleId>
            <ArticleId IdType="pubmed">20129170</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Georgakopoulos A, Xu J, Xu C, Mauger G, Barthet G, Robakis NK. Presenilin1gamma-secretase promotes the EphB2-induced phosphorylation of ephrinB2 by regulating phosphoprotein associated with glycosphingolipid-enriched microdomainsCsk binding protein. FASEB J
2011; 25:3594-604; PMID:21746865; http://dx.doi.org/10.1096/fj.11-187856</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1096/fj.11-187856</ArticleId>
            <ArticleId IdType="pmc">PMC3177584</ArticleId>
            <ArticleId IdType="pubmed">21746865</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Playford MP, Schaller MD. The interplay between Src and integrins in normal and tumor biology. Oncogene
2004; 23:7928-46; PMID:15489911; http://dx.doi.org/10.1038/sj.onc.1208080</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/sj.onc.1208080</ArticleId>
            <ArticleId IdType="pubmed">15489911</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Kanou T, Oneyama C, Kawahara K, Okimura A, Ohta M, Ikeda N, Shintani Y, Okumura M, Okada M. The transmembrane adaptor CbpPAG1 controls the malignant potential of human non–small celllung cancers that have c-Src upregulation. Mol Cancer Res
2011; 9:103-14; PMID:21156787; http://dx.doi.org/10.1158/1541-7786.MCR-10-0340</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1158/1541-7786.MCR-10-0340</ArticleId>
            <ArticleId IdType="pubmed">21156787</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Grant SG, O’Dell TJ, Karl KA, Stein PL, Soriano P, Kandel ER. Impaired long-term potentiation, spatial learning, and hippocampal development in fyn mutant mice. Science
1992; 258:1903-10; PMID:1361685; http://dx.doi.org/10.1126/science.1361685</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1126/science.1361685</ArticleId>
            <ArticleId IdType="pubmed">1361685</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Lu YM, Roder JC, Davidow J, Salter MW. Src activation in the tnduction of long-term potentiation in CA1 hippocampal neurons. Science
1998; 279:1363-8; PMID:9478899; http://dx.doi.org/10.1126/science.279.5355.1363</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1126/science.279.5355.1363</ArticleId>
            <ArticleId IdType="pubmed">9478899</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Henderson JT, Georgiou J, Jia Z, Robertson J, Elowe S, Roder JC, Pawson T. The receptor tyrosine kinase EphB2 regulates NMDA-dependent synaptic function. Neuron
2001; 32:1041-56; PMID:11754836; http://dx.doi.org/10.1016/S0896-6273(01)00553-0</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/S0896-6273(01)00553-0</ArticleId>
            <ArticleId IdType="pubmed">11754836</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Ionides EL, Fang KS, Rivkah Isseroff R, Oster GF. Stochastic models for cell motion and taxis. J Math Biol
2004; 48:23-37; PMID:14685770; http://dx.doi.org/10.1007/s00285-003-0220-z</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s00285-003-0220-z</ArticleId>
            <ArticleId IdType="pubmed">14685770</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Danysz W, Parsons CG. Alzheimer's disease, beta-amyloid, glutamate, NMDA receptors and memantine–searching for the connections. Br J Pharmacol
2012; 167:324-52; PMID:22646481; http://dx.doi.org/10.1111/j.1476-5381.2012.02057.x</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/j.1476-5381.2012.02057.x</ArticleId>
            <ArticleId IdType="pmc">PMC3481041</ArticleId>
            <ArticleId IdType="pubmed">22646481</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Snyder EM, Nong Y, Almeida CG, Paul S, Moran T, Choi EY, Nairn AC, Salter MW, Lombroso PJ, Gouras GK. Regulation of NMDA receptor trafficking by amyloid-beta. Nat Neurosci
2005; 8:1051-8; PMID:16025111; http://dx.doi.org/10.1038/nn1503</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/nn1503</ArticleId>
            <ArticleId IdType="pubmed">16025111</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Inoue E, Deguchi-Tawarada M, Togawa A, Matsui C, Arita K, Katahira-Tayama S, Sato T, Yamauchi E, Oda Y, Takai Y. Synaptic activity prompts gamma-secretase-mediated cleavage of EphA4 and dendritic spine formation. J Cell Biol
2009; 185:551-64; PMID:19414612; http://dx.doi.org/10.1083/jcb.200809151</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1083/jcb.200809151</ArticleId>
            <ArticleId IdType="pmc">PMC2700400</ArticleId>
            <ArticleId IdType="pubmed">19414612</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Matsui C, Inoue E, Kakita A, Arita K, Deguchi-Tawarada M, Togawa A, Yamada A, Takai Y, Takahashi H. Involvement of the gamma-secretase-mediated EphA4 signaling pathway in synaptic pathogenesis of Alzheimer's disease. Brain Pathol
2012; 22:776-87; PMID:22404518; http://dx.doi.org/10.1111/j.1750-3639.2012.00587.x</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/j.1750-3639.2012.00587.x</ArticleId>
            <ArticleId IdType="pubmed">22404518</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Hedstrom L. Serine protease mechanism and specificity. Chem Rev
2002; 102:4501-24; PMID:12475199; http://dx.doi.org/10.1021/cr000033x</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1021/cr000033x</ArticleId>
            <ArticleId IdType="pubmed">12475199</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Polgar L. The catalytic triad of serine peptidases. Cellular and molecular life sciences : CMLS
2005; 62:2161-72; PMID:16003488; http://dx.doi.org/10.1007/s00018-005-5160-x</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s00018-005-5160-x</ArticleId>
            <ArticleId IdType="pubmed">16003488</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Netzel-Arnett S, Hooper JD, Szabo R, Madison EL, Quigley JP, Bugge TH, Antalis TM. Membrane anchored serine proteases: a rapidly expanding group of cell surface proteolytic enzymes with potential roles in cancer. Cancer Metastasis Rev
2003; 22:237-58; PMID:12784999; http://dx.doi.org/10.1023/A:1023003616848</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1023/A:1023003616848</ArticleId>
            <ArticleId IdType="pubmed">12784999</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
M. Santos J, Graindorge A, Soldati-Favre D. New insights into parasite rhomboid proteases. Mol Biochem Parasitol
2012; 182:27-36; PMID:22173057; http://dx.doi.org/10.1016/j.molbiopara.2011.11.010</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.molbiopara.2011.11.010</ArticleId>
            <ArticleId IdType="pubmed">22173057</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Lemberg MK, Menendez J, Misik A, Garcia M, Koth CM, Freeman M. 
Mechanism of intramembrane proteolysis investigated with purified rhomboid proteases. EMBO J
2005; 24:464-72.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC548647</ArticleId>
            <ArticleId IdType="pubmed">15616571</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Lee JR, Urban S, Garvey CF, Freeman M. Regulated intracellular ligand transport and proteolysis control EGF signal activation in drosophila. Cell
2001; 107:161-71; PMID:11672524; http://dx.doi.org/10.1016/S0092-8674(01)00526-8</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/S0092-8674(01)00526-8</ArticleId>
            <ArticleId IdType="pubmed">11672524</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Adrain C, Strisovsky K, Zettl M, Hu L, Lemberg MK, Freeman M. Mammalian EGF receptor activation by the rhomboid protease RHBDL2. EMBO Rep
2011; 12:421-7; PMID:21494248; http://dx.doi.org/10.1038/embor.2011.50</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/embor.2011.50</ArticleId>
            <ArticleId IdType="pmc">PMC3090019</ArticleId>
            <ArticleId IdType="pubmed">21494248</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Pascall JC, Brown KD. Intramembrane cleavage of ephrinB3 by the human rhomboid family protease, RHBDL2. Biochem Biophys Res Commun
2004; 317:244-52; PMID:15047175; http://dx.doi.org/10.1016/j.bbrc.2004.03.039</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.bbrc.2004.03.039</ArticleId>
            <ArticleId IdType="pubmed">15047175</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Chen ZL, Yoshida S, Kato K, Momota Y, Suzuki J, Tanaka T, Ito J, Nishino H, Aimoto S, Kiyama H, et al. . 
Expression and activity-dependent changes of a novel limbic-serine protease gene in the hippocampus. J Neurosci
1995; 15:5088-97; PMID:7623137</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC6577896</ArticleId>
            <ArticleId IdType="pubmed">7623137</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Kishi T, Kato M, Shimizu T, Kato K, Matsumoto K, Yoshida S, Shiosaka S, Hakoshima T. Crystal structure of neuropsin, a hippocampal protease involved in kindling epileptogenesis. J Biol Chem
1999; 274:4220-4; PMID:9933620; http://dx.doi.org/10.1074/jbc.274.7.4220</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1074/jbc.274.7.4220</ArticleId>
            <ArticleId IdType="pubmed">9933620</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Shiosaka S, Ishikawa Y. Neuropsin—A possible modulator of synaptic plasticity. J Chem Neuroanat
2011; 42:24-9; PMID:21679765; http://dx.doi.org/10.1016/j.jchemneu.2011.05.014</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.jchemneu.2011.05.014</ArticleId>
            <ArticleId IdType="pubmed">21679765</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Attwood BK, Bourgognon J-M, Patel S, Mucha M, Schiavon E, Skrzypiec AE, Young KW, Shiosaka S, Korostynski M, Piechota M, et al. . 
Neuropsin cleaves EphB2 in the amygdala to control anxiety. Nature
2011; 473:372-5; PMID:21508957; http://dx.doi.org/10.1038/nature09938</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/nature09938</ArticleId>
            <ArticleId IdType="pmc">PMC3145099</ArticleId>
            <ArticleId IdType="pubmed">21508957</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
